# Merck KGaA says MS drug has blockbuster potential; key data expected in December
**Stock News**

**2023-10-19 08:05**

**https://www.ainvest.com/news/merck-kgaa-says-ms-drug-has-blockbuster-potential-key-data-expected-in-december-231010004991f4974b6848a2/**

The CEO of Germany’s Merck KGaA said the company’s experimental multiple sclerosis drug can be a “blockbuster”, an industry term for annual sales that exceed $1 billion, even after concerns emerged that it may cause liver damage.